Cholangiocarcinoma — evolving concepts and therapeutic strategies

Cited by (1,001)

Items 501–600 of 1,001

1. Knockdown of lncRNA SNHG20 Suppressed the Proliferation of Cholangiocarcinoma by Sponging miR-520f-3p
   Canghai Guan, Yuqiao Zhao, Weina Wang, Zengtao Hu, Lang Liu, Wenzhi Li, Xingming Jiang · 2020 · Cancer Biotherapy and Radiopharmaceuticals
2. A potential role for aspirin in the prevention and treatment of cholangiocarcinoma
   Xizi Shen, Xingping Shen · 2020 · International Journal of Cancer
3. Experimental HER2- targeted therapies for biliary tract cancer
   Alessandro Rizzo, Angela Dalia Ricci, Chiara Bonucci, Nastassja Tober, Andrea Palloni, Giorgio Frega, Giovanni Brandi · 2020 · Expert Opinion on Investigational Drugs
4. Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cells
   Tawit Suriyo, Mayuree Fuangthong, Charlermchai Artpradit, Teerapat Ungtrakul, Thaniya Sricharunrat, Fatma Taha, Jutamaad Satayavivad · 2021 · European Journal of Pharmacology
5. Extrahepatic cholangiocarcinoma: Current status of endoscopic approach and additional therapies
   Alina Ioana Tanțău, Alina Mândruţiu, Anamaria Pop, Roxana Delia Zaharie, Dana Crișan, Carmen Monica Preda, Marcel Vasile Tantau, Voicu Mercea · 2021 · World Journal of Hepatology
6. GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration
   Jun Zhou, Ranglang Huang, 聂晚频, Jiajia Yuan, Zeyu Zhang, Liangliang Mi, Changfa Wang · 2021 · Oncology Reports
7. The Prognostic Value of Systemic Inflammation Response Index in Cholangiocarcinoma Patients
   Bao Jin, Wenmo Hu, Si Su, Haifeng Xu, Xin Lü, Xinting Sang, Huayu Yang, Yilei Mao, Shunda Du · 2021 · Cancer Management and Research
8. MiR-155-5p suppresses SOX1 to promote proliferation of cholangiocarcinoma via RAF/MEK/ERK pathway
   Da Wang, Fei Xiong, Guanhua Wu, Wenzheng Liu, Bing Wang, Yongjun Chen · 2021 · Cancer Cell International
9. PIWIL4 and SUPT5H combine to predict prognosis and immune landscape in intrahepatic cholangiocarcinoma
   Wenbo Zou, Zizheng Wang, Xiuping Zhang, Shuai Xu, Fei Wang, Lincheng Li, Zhaoda Deng, Jing Wang, Ke Pan, Xinlan Ge et al. · 2021 · Cancer Cell International
10. CD105: tumor diagnosis, prognostic marker and future tumor therapeutic target
    Lan Li, Liping Zhong, Chao Tang, Lu Gan, Tong Mo, Jintong Na, Jian He, Yong Huang · 2022 · Clinical & Translational Oncology
11. Biomarkers of intrahepatic cholangiocarcinoma: diagnosis and response to therapy
    Zachary J. Brown, Daniel Brock Hewitt, Timothy Michael Pawlik · 2022 · Frontiers in Bioscience-Landmark
12. SPARC induces M2 polarization of macrophages to promote proliferation, migration, and angiogenesis of cholangiocarcinoma cells
    Shikang Deng, Yun Jin, Yan Jin, Junfeng Wang · 2022 · Neoplasma
13. Cholangiocarcinoma in the Era of Immunotherapy
    Eleni Manthopoulou, Daryl Ramai, Jahnvi Dhar, Jayanta Samanta, Alexandros Ioannou, Ekaterina Lusina, Rodolfo Sacco, Antonio Facciorusso · 2023 · Vaccines
14. Piperlongumine-Eluting Gastrointestinal Stent Using Reactive Oxygen Species-Sensitive Nanofiber Mats for Inhibition of Cholangiocarcinoma Cells
    Hyung Ha Jang, Su Bum Park, Jeong Sup Hong, Hye Lim Lee, Yeon Hui Song, Jungsoo Kim, Yun Hye Jung, Chan Hyeok Kim, Doo-Man Kim, Sang Eun Lee et al. · 2019 · Nanoscale Research Letters
15. The prognostic impact of preoperative CA19-9 on resectable cholangiocarcinoma: a comprehensive systematic review and meta-analysis
    Zhicong Wang, Yabo Shi, Ganwei Xiong, Mengxi Han, Xiaoliang Chen · 2024 · Discover Oncology
16. Identification of biomarkers associated with exhausted CD8 + T cells in the tumor microenvironment of intrahepatic cholangiocarcinoma based on Mendelian randomization and bioinformatics analysis
    Liuxing Feng, Quan Yuan, Hao Yu, Rongjie Ye, ZhenHao Xie, JiaHuan Xu, Xiu-Dong Li, Shuangjia Wang · 2025 · Discover Oncology
17. Minimizing the risk of small-for-size syndrome after liver surgery
    Michail Papamichail, Michail Pizanias, Nigel David Heaton · 2021 · Hepatobiliary & pancreatic diseases international
18. Suppression of histone deacetylase 1 by JSL-1 attenuates the progression and metastasis of cholangiocarcinoma via the TPX2/Snail axis
    Lu Xu, Weizhong Yang, Jinhui Che, Deqiang Li, Haihong Wang, Yunjiu Li, Wuyuan Zhou · 2022 · Cell Death and Disease
19. The role of neo-adjuvant therapy in cholangiocarcinoma: A systematic review
    Sinead Cremen, Michael Eamon Kelly, Tom K. Gallagher · 2022 · Frontiers in Oncology
20. A combination therapy of bortezomib, CXCR4 inhibitor, and checkpoint inhibitor is effective in cholangiocarcinoma in vivo
    Ling Li, Yang Zhou, Yicheng Zhang, Hai‐Jie Hu, Hai‐Quan Mao, Florin M. Selaru · 2023 · iScience
21. Comparison of hepatic arterial infusion chemotherapy with mFOLFOX vs. first-line systemic chemotherapy in patients with unresectable intrahepatic cholangiocarcinoma
    Zhenyun Yang, Yizhen Fu, Weijie Wu, Zili Hu, Yangxun Pan, Juncheng Wang, Jinbin Chen, Dandan Hu, Zhongguo Zhou, Minshan Chen et al. · 2023 · Frontiers in Pharmacology
22. Non-coding RNA and Drug resistance in cholangiocarcinoma
    Zhaowei Wu, Shiming Jiang, Yong Chen · 2023 · Non-coding RNA Research
23. The heterogeneity of signaling pathways and drug responses in intrahepatic cholangiocarcinoma with distinct genetic mutations
    Yangyang Feng, Ming Zhao, Lijian Wang, Ling Li, Josh Haipeng Lei, Jingbo Zhou, Jinghong Chen, Yumeng Wu, Kai Miao, Chu‐Xia Deng · 2024 · Cell Death and Disease
24. Cuproptosis-related genes score and its hub gene GCSH: A novel predictor for cholangiocarcinomas prognosis based on RNA seq and experimental analyses
    Rui Rochelle He, Yihu Li, Pengcheng Jiao, Yingbin Huang, Shuyi Dong, Liqiu Mo, Xingyuan Jiao · 2024 · Journal of Cancer
25. Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid Tumors
    Gyöngyvér Szentmártoni, Dorottya Mühl, Renata Csanda, Attila Marcell Szász, Zoltán Herold, Magdolna Dank · 2024 · Biomedicines
26. lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma
    Gongcai Qiu, Donglai Ma, Fujun Li, Dongsheng Sun, Zhaolin Zeng · 2019 · International Journal of Oncology
27. An Immune–Magnetophoretic Device for the Selective and Precise Enrichment of Circulating Tumor Cells from Whole Blood
    Chaithanya Chelakkot, Jiyeon Ryu, Mi Young Kim, Jin-Soo Kim, Dohyeong Kim, Juhyun Hwang, Sung Hoon Park, Seok Bum Ko, Jeong Won Park, Moon Youn Jung et al. · 2020 · Micromachines
28. Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection
    Jian Zhao, Wei Zhang, Jun Zhang, Yi Zhang, Wenjie Ma, Si-Yun Liu, Fu‐Yu Li, Bin Song · 2020 · BMC Cancer
29. Co-Clinical Trials: An Innovative Drug Development Platform for Cholangiocarcinoma
    Brinda Balasubramanian, Simran Venkatraman, Kyaw Zwar Myint, Tavan Janvilisri, Kanokpan Wongprasert, Supeecha Kumkate, David O. Bates, Rutaiwan Tohtong · 2021 · Pharmaceuticals
30. Protein‑loss of SWI/SNF‑complex core subunits influences prognosis dependent on histological subtypes of intra‑ and extrahepatic cholangiocarcinoma
    Britta Janina Wagner, Patrick Sven Plum, Katharina Apel, Marie Scherer, Denise Buchner, Sebastian Brinkmann, Reinhard Buettner, Dirk Ludger Stippel, Alexander Quaas, Uta Drebber · 2021 · Oncology Letters
31. LncRNA ST8SIA6-AS1 Promotes Cholangiocarcinoma Progression by Suppressing the miR-145-5p/MAL2 Axis
    Junchuang He, Hongxian Yan, Sidong Wei, Guoyong Chen · 2021 · OncoTargets and Therapy
32. Dihydromyricetin Inhibits Tumor Growth and Epithelial-Mesenchymal Transition through regulating miR-455-3p in Cholangiocarcinoma
    Xin Li, Zhousheng Yang, Wenwu Cai, Yang Deng, Lei Chen, Shenglan Tan · 2021 · Journal of Cancer
33. Systemic Sequential Therapy of CisGem, Tislelizumab, and Lenvatinib for Advanced Intrahepatic Cholangiocarcinoma Conversion Therapy
    Yuan Ding, Xin Han, Zhongquan Sun, Jinlong Tang, Yingsheng Wu, Weilin Wang · 2021 · Frontiers in Oncology
34. A Bibliometric Analysis of 8,276 Publications During the Past 25 Years on Cholangiocarcinoma by Machine Learning
    Zeyu Zhang, Zhiming Wang, Yun Huang · 2021 · Frontiers in Oncology
35. Role of autophagy in cholangiocarcinoma: An autophagy-based treatment strategy
    Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Athanasios G. Papavassiliou, Michalis V. Karamouzis · 2021 · World Journal of Gastrointestinal Oncology
36. An Insight into Cholangiocarcinoma and Recent Advances in its Treatment
    Rakesh Sahu, Praveen Rishi nee Sharma, Ajay Kumar · 2022 · Journal of Gastrointestinal Cancer
37. Steroidal saponins from Trillium tschonoskii rhizome repress cancer stemness and proliferation of intrahepatic cholangiocarcinoma
    Xu Pang, Lingfei Wan, Jie Yang, Peiying Bai, Jie Zhang, Xiaojuan Chen, Xinlong Yan, Baiping Ma · 2022 · Bioorganic Chemistry
38. Roles of fusion genes in digestive system cancers: Dawn for cancer precision therapy
    Yaqing Zhang, Jie Sun, Yongxi Song, Peng Gao, Xin Wang, Miao Chen, Yuan Li, Zhonghua Wu · 2022 · Critical Reviews in Oncology/Hematology
39. Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer
    Amanda N. Ruggieri, Mark M. Yarchoan, Subir Goyal, Yuan Liu, Elad Sharon, Helen X. Chen, Brian M. Olson, Chrystal Mary Paulos, Bassel F. El‐Rayes, Shishir Kumar Maithel et al. · 2022 · Clinical Cancer Research
40. An Expert, Multidisciplinary Perspective on Best Practices in Biomarker Testing in Intrahepatic Cholangiocarcinoma
    David C. Madoff, Nadine Abi‐Jaoudeh, David R. Braxton, Lipika Goyal, Dhanpat Jain, Bruno Calazans Odisio, Riad Salem, Mark Andrew Schattner, Rahul A. Sheth, Daneng Li · 2022 · The Oncologist
41. Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study
    Yen‐Chun Peng, Cheng‐Li Lin, Wan-Yun Hsu, Wai-Keung Chow, Show-Wu Lee, Hong‐Zen Yeh, Chia‐Chang Chen, Chia‐Hung Kao · 2018 · Frontiers in Pharmacology
42. Receptor-Interacting Protein Kinase 1 Promotes Cholangiocarcinoma Proliferation And Lymphangiogenesis Through The Activation Protein 1 Pathway
    Cheng-Zong Li, Yu-Xiang Lin, Tiancong Huang, Juanyong Pan, Gaoxiong Wang · 2019 · OncoTargets and Therapy
43. Expression of fibroblast activation protein and the clinicopathological relevance in distal cholangiocarcinoma
    Johannes Byrling, Agata Sasor, Johan Nilsson, Katarzyna Said Hilmersson, Roland E. Andersson, Bodil Andersson · 2020 · Scandinavian Journal of Gastroenterology
44. Combining Immunoscore with Clinicopathologic Features in Cholangiocarcinoma: An Influential Prognostic Nomogram
    Zi-you Wu, Wei Shen, Juanqing Yue, Wenyan Yao, Shilei Liu, Yunpeng Jin, Ping Dong, Fei Ma, Xiangsong Wu, Wei Gong · 2020 · OncoTargets and Therapy
45. Selecting an Appropriate Experimental Animal Model for Cholangiocarcinoma Research
    Man Li, Xueli Zhou, Wei Wang, Baoan Ji, Yu‐Yun Shao, Qianyu Du, Jinghao Yao, Yan Fang Yang · 2022 · Journal of Clinical and Translational Hepatology
46. Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue
    Giovanni Brandi, Chiara Deiana, Linda Galvani, Andrea Palloni, Angela Dalia Ricci, Alessandro Rizzo, Simona Tavolari · 2023 · Frontiers in Oncology
47. Safety and efficacy of neoadjuvant chemotherapy based on our resectability criteria for locally advanced perihilar cholangiocarcinoma
    Kazuyuki Gyoten, Naohisa Kuriyama, Koki Maeda, Takahiro Ito, Aoi Hayasaki, Takehiro Fujii, Yusuke Iizawa, Akihiro Tanemura, Yasuhiro Murata, Masashi Kishiwada et al. · 2023 · Langenbeck s Archives of Surgery
48. Cellular Senescence in Liver Cancer: How Dying Cells Become “Zombie” Enemies
    Aurora Gazzillo, Camilla Volponi, Cristiana Soldani, Michela Anna Polidoro, Barbara Franceschini, Ana Lleò, Eduardo Bonavita, Matteo Donadon · 2023 · Biomedicines
49. RPL35A promotes the progression of cholangiocarcinoma by mediating HSPA8 ubiquitination
    Chengshuo Zhang, Yu Wang, Gang Wu, Ning Sun, Han Bai, Xuejian Li, Shuai Han, Haonan Zhou, Ruizhao Qi, Jialin Zhang · 2024 · Biology Direct
50. Single-cell analysis defines LGALS1+ fibroblasts that promote proliferation and migration of intrahepatic cholangiocarcinoma
    Qiqi Cao, Jinxian Yang, Lixuan Jiang, Zhao Yang, Zhecai Fan, Shuzhen Chen, Sibo Zhu, Lei Yin, Hongyang Wang, Wen Wen · 2024 · Journal of Molecular Cell Biology
51. Chlorogenic Acid as a Potential Therapeutic Agent for Cholangiocarcinoma
    Jia-bao Liang, Tong Wen, Xiaojian Zhang, Xiaoling Luo · 2024 · Pharmaceuticals
52. Strategies for treating the cold tumors of cholangiocarcinoma: core concepts and future directions
    GuanBo Zhang, Jinsong Li, Gang Li, Jie Zhang, Zhi Ping Yang, Lin Yang, ShiJie Jiang, JiaXing Wang · 2024 · Clinical and Experimental Medicine
53. UCK2 promotes intrahepatic cholangiocarcinoma progression and desensitizes cisplatin treatment by PI3K/AKT/mTOR/autophagic axis
    Xiwen Wu, Da Chen, Muqi Li, Gehao Liang, Huizhen Ye · 2024 · Cell Death Discovery
54. Prognosis related to treatment plan in patients with biliary tract cancer: A nationwide database study
    Diana Elena Renteria Ramirez, Lucas Alexander Knøfler, Jakob Kirkegård, Claus Wilki Fristrup, Mogens T. Stender, Susanne Dam Nielsen, Alice Markussen, Peter Nørgaard Larsen, D. Akdag, Hasan Ahmad Al-Saffar et al. · 2024 · Cancer Epidemiology
55. Inflammation-based prognostic scores in patients with extrahepatic bile duct lesions treated by percutaneous transhepatic biliary stenting combined with 125I seeds intracavitary irradiation
    X. Hu, Qing Pang, H. Liu, Zhen Qian, Hao Jin, Lei Zhou, Yifei Wang, Zhongran Man, Z. Li, Shuai Yang · 2018 · Clinical & Translational Oncology
56. Prognostic value of the controlling nutritional status (CONUT) score in intrahepatic cholangiocarcinoma patients especially who had long-time alcohol consumption
    Yiling Zheng, Fan Wu, Weiqi Rong, Yunhe Liu, Tana Siqin, Liming Wang, Jianxiong Wu · 2020 · Journal of Clinical Biochemistry and Nutrition
57. [Retracted] Overexpression of 14‐3‐3σ Modulates Cholangiocarcinoma Cell Survival by PI3K/Akt Signaling
    Qiao Wu, Hua Fan, Ren Lang, Xianliang Li, Xingmao Zhang, Shaocheng Lv, Qiang He · 2020 · BioMed Research International · Retracted
58. Arsenic trioxide enhances the chemotherapeutic efficiency of cisplatin in cholangiocarcinoma cells via inhibiting the 14-3-3ε-mediated survival mechanism
    Ming Li Jin, Liunan Wu, Shuai Chen, Rong Cai, Yi Dai, Haojun Yang, Liming Tang, Yuan Li · 2020 · Cell Death Discovery
59. Development of a Prognostic Signature Based on Single-Cell RNA Sequencing Data of Immune Cells in Intrahepatic Cholangiocarcinoma
    Miao Su, Kuangyuan Qiao, Xiao‐Li Xie, Xinying Zhu, Fu-Lai Gao, Changjuan Li, Dong-qiang Zhao · 2021 · Frontiers in Genetics
60. Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge
    Simone Carotti, Maria Zingariello, Maria Angela Francesconi, Laura D’Andrea, Maria Ujue Latasa, Leticia Colyn, Maite G. Fernández‐Barrena, Rocco Simone Flammia, Mario Falchi, Daniela Righi et al. · 2021 · Oncogene
61. Avasimibe Dampens Cholangiocarcinoma Progression by Inhibiting FoxM1-AKR1C1 Signaling
    Yunshu Gao, Dongyun Xu, Hongwei Li, Jiahua Xu, Yating Pan, Xinyi Liao, Jianxin Qian, Yi Hu, Guanzhen Yu · 2021 · Frontiers in Oncology
62. Irreversible Electroporation Treatment With Intraoperative Biliary Stenting for Unresectable Perihilar Cholangiocarcinoma: A Pilot Study
    Po-Chih Yang, Yan-Jun Chen, Xiao-Yong Li, Chih‐Yang Hsiao, Bing-Bing Cheng, Yu Gao, Bai-Zhong Zhou, Shengyang Chen, Shuiquan Hu, Quan Zeng et al. · 2021 · Frontiers in Oncology
63. Development and validation of an online calculator to predict early recurrence and long‐term survival in patients with distal cholangiocarcinoma after pancreaticoduodenectomy
    Shuai Xu, Xiu‐Ping Zhang, Guodong Zhao, Zhi‐Ming Zhao, Yuan‐Xing Gao, Minggen Hu, Xiang‐Long Tan, Rong Liu · 2021 · Journal of Hepato-Biliary-Pancreatic Sciences
64. Epigenetic Silencing of 15-Hydroxyprostaglandin Dehydrogenase by Histone Methyltransferase EHMT2/G9a in Cholangiocarcinoma
    Jinqiang Zhang, Weina Chen, Wenbo Ma, Kyoungsub Song, Sean Bong Lee, Chang Han, Tong Wu · 2021 · Molecular Cancer Research
65. Cholangiocarcinoma: the role of genetic and epigenetic factors; current and prospective treatment with checkpoint inhibitors and immunotherapy.
    Panagiotis Sarantis, Eleftheria Dikoglou-Tzanetatou, Evangelia Ioakeimidou, Christos Vallilas, Θεόδωρος Ανδρουτσάκος, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, Athanasios G. Papavassiliou, Michalis V. Karamouzis · 2021 · PubMed Central
66. Circ_0000591 served as endogenous RNA for miR-326 to promote progression of cholangiocarcinoma via the TLR4/MyD88/IL6 axis
    Fenqiang Xiao, Fei Xu, Hua Zhang, Xiaoming Shuai · 2022 · Biochemical and Biophysical Research Communications
67. Validation and Characterization of FGFR2 Rearrangements in Cholangiocarcinoma with Comprehensive Genomic Profiling
    Ian M. Silverman, Meijuan Li, Karthikeyan Murugesan, Melanie A. Krook, Milind M. Javle, Robin Kate Kelley, Mitesh J. Borad, Sameek Roychowdhury, Wei Meng, Bahar Yilmazel et al. · 2022 · Journal of Molecular Diagnostics
68. mRNA vaccine development for cholangiocarcinoma: a precise pipeline
    Tianyu Tang, Xing Huang, Gang Zhang, Minghao Lu, Tingbo Liang · 2022 · Military Medical Research
69. Brusatol suppresses the growth of intrahepatic cholangiocarcinoma by PI3K/Akt pathway
    Ziyan Chen, Bangjie He, Jungang Zhao, Jiacheng Li, Yifeng Zhu, Leilei Li, Wenming Bao, Jiuyi Zheng, Haitao Yu, Gang Chen · 2022 · Phytomedicine
70. Multi-omics analysis revealed the role of extracellular vesicles in hepatobiliary & pancreatic tumor
    Xiangdong Gongye, Ming Tian, Peng Xia, Chengming Qu, Zhang Chen, Jigang Wang, Qian Zhu, Zhijie Li, Yufeng Yuan · 2022 · Journal of Controlled Release
71. Surgical Aspects of Intrahepatic Cholangiocarcinoma
    Amram Kupietzky, Arié Ariche · 2022 · Cancers
72. Role of the Angiogenic Factors in Cholangiocarcinoma
    Romina Mancinelli, Caterina Loredana Mammola, Roberta Sferra, Simona Pompili, Antonella Vetuschi, Luigi Pannarale · 2019 · Applied Sciences
73. Mixed adenoendocrine carcinoma in the extrahepatic biliary tract: A case report and literature review
    Liang Zhang, Zhengtao Yang, Qing Chen, Mengxia Li, Xiaolu Zhu, Dalong Wan, Haiyang Xie, Shusen Zheng · 2019 · Oncology Letters
74. Baicalein mediates anticancer effect on cholangiocarcinoma through co-targeting the AKT/NF-κB and STAT3 signaling pathway
    Peng Han, Jin Shang, Dan-Ling Chen, Si‐Yang Li, Rui Fan, Ruihan Li, Huiqi Li, Shiyang Zhang, Dong‐Yan Shen · 2021 · Process Biochemistry
75. Serum microRNAs as Biomarkers for the Noninvasive Early Diagnosis of Biliary Tract Cancer
    Yueting Han, Haiyang Zhang, Zhengyang Zhou, Rui Liu, Dongying Liu, Ming Bai, Qian Fan, Jialu Li, Kegan Zhu, Hongli Li et al. · 2021 · International Journal of General Medicine
76. ITGB6-Knockout Suppresses Cholangiocarcinoma Cell Migration and Invasion with Declining PODXL2 Expression
    Yurie Soejima, Miho Takeuchi, Nao Miyamoto, Motoji Sawabe, Toshio Fukusato · 2021 · International Journal of Molecular Sciences
77. Cholangiocarcinoma: The era of liquid biopsy
    Evgenia Kotsifa, Francesca Saffioti, Vasileios K. Mavroeidis · 2025 · World Journal of Gastroenterology
78. Stiffness‐Tunable Hydrogel Microfluidic Chip Reveals the Role of Stiffness in Cholangiocarcinoma Invasion and Pre‐Metastatic Niche Formation
    Lin Wu, Guohua Wu, Di Wu, Wenqi Hu, Qijun Du, Qinrui Lu, Jiashu Wang, Ao Xie, Youlong Yang, Jie Liu et al. · 2025 · Advanced Healthcare Materials
79. Bibliometric Insights in Advances of Anaplastic Thyroid Cancer: Research Landscapes, Turning Points, and Global Trends
    Hanyu Wang, Yuxin Yu, Kang Wang, Hui Sun · 2021 · Frontiers in Oncology
80. Pathological images for personal medicine in Hepatocellular carcinoma: Cross-talk of gene sequencing and pathological images
    Yang Li, Kun Deng, ZHIQIANG MOU, Ping-fu Xiong, JIAN WEN, JING LI · 2022 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
81. Unraveling the heterogeneity of cholangiocarcinoma and identifying biomarkers and therapeutic strategies with single-cell sequencing technology
    Wangyang Chen, Dongchao Xu, Qiang Liu, Yirong Wu, Yu Wang, Jianfeng Yang · 2023 · Biomedicine & Pharmacotherapy
82. The possible role of Helicobacter pylori in liver diseases
    Mahnaz Mohammadi, Adeleh Attar, Maryam Mohammadbeigi, Amir Peymani, Shahin Bolori, Fatemeh Fardsanei · 2023 · Archives of Microbiology
83. Programmed Cell Death Pathways in Cholangiocarcinoma: Opportunities for Targeted Therapy
    Manuel Scimeca, Valentina Rovella, Valeria Palumbo, Maria Paola Scioli, Rita Bonfiglio, Gerry Melino, Mauro Piacentini, Luigi Frati, Massimiliano Agostini, Eleonora Candi et al. · 2023 · Cancers
84. FGD5 as a novel prognostic biomarker and its association with immune infiltrates in lung adenocarcinoma
    ZHONGXIANG TANG, LILI WANG, GUOJUN WU, LING QIN, Yurong Tan · 2023 · Biocell
85. LOXL1-AS1 inhibits JAK2 ubiquitination and promotes cholangiocarcinoma progression through JAK2/STAT3 signaling
    Shaobo Yu, Xin Gao, Sidi Liu, Xiangjun Sha, Siyuan Zhang, Xinmiao Zhang, Dongsheng Sun, Xingming Jiang · 2024 · Cancer Gene Therapy
86. Metabolome-wide association identifies altered metabolites and metabolic pathways in the serum of patients with cholangiocarcinoma
    Linsey E. Jackson, Jennifer L. Tomlinson, Roberto Alva‐Ruiz, Lindsey A. Gregory, Seul Kee Byeon, Amro M. Abdelrahman, Dong‐Gi Mun, Caroline W. Grant, Zachary C. Fogarty, Chen Wang et al. · 2024 · JHEP Reports
87. Trastuzumab, a monoclonal anti-HER2 antibody modulates cytotoxicity against cholangiocarcinoma via multiple mechanisms
    Jutatip Panaampon, Prin Sungwan, Sawako Fujikawa, Somponnat Sampattavanich, Siwanon Jirawatnotai, Seiji Okada · 2024 · International Immunopharmacology
88. Unveil Intrahepatic Cholangiocarcinoma Heterogeneity through the Lens of Omics and Multi-Omics Approaches
    Veronica Porreca, Cristina Barbagallo, Eleonora Corbella, Marco Peres, Michele Stella, Giuseppina Mignogna, Bruno Maras, Marco Ragusa, Carmine Mancone · 2024 · Cancers
89. The risk of hepatobiliary complications in Clonorchis and Opisthorchis infection: A systematic review and meta-analysis
    Yilin Huang, Kaiyan Zhang, Yan-Lin Sun, Men‐Bao Qian, Zhaojun Wang · 2024 · Acta Tropica
90. Tumor-initiating cells escape tumor immunity via CCL8 from tumor-associated macrophages in mice
    Shuang Chen, Chen‐Song Huang, Kang Li, Maosheng Cheng, Caihua Zhang, Jianqi Xiong, Guoli Tian, Ruoxing Zhou, Rongsong Ling, Xiaochen Wang et al. · 2025 · Journal of Clinical Investigation
91. Multi-omics approaches for identifying the PANoptosis signature and prognostic model via a multimachine-learning computational framework for intrahepatic cholangiocarcinoma
    Yanxi Yu, Yan You, Yuxin Duan, Meiqing Kang, Baoyong Zhou, Jian Yang, Kun-Li Yin, Wentao Ye, Ranning Xu, Haolin Wang et al. · 2025 · Hepatology
92. Promising Gene Therapy Using an Adenovirus Vector Carrying REIC/Dkk-3 Gene for the Treatment of Biliary Cancer
    Emi Tanaka, Daisuke Uchida, Hidenori Shiraha, Hironari Kato, Atsushi Ohyama, Masaya Iwamuro, Masami Watanabe, Hiromi Kumon, Hiroyuki Okada · 2020 · Current Gene Therapy
93. Liver Transplantation for Cholangiocarcinoma: Insights into the Prognosis and the Evolving Indications
    Guergana G. Panayotova, Flavio Paterno, James V. Guarrera, Keri E. Lunsford · 2020 · Current Oncology Reports
94. KIF4A as a novel prognostic biomarker in cholangiocarcinoma
    Dengyong Zhang, Shuo Shuo, Wanliang Sun, Xue Lv, Zheng Lü · 2021 · Medicine
95. MicroRNA-455-5p Contributes to Cholangiocarcinoma Growth and Mediates Galangin's Anti-Tumor Effects
    Xu Deng, Meiling Zuo, Zhifang Pei, Yuanlin Xie, Zhong‐Bao Yang, Zhihui Zhang, Minna Jiang, Da‐Bin Kuang · 2021 · Journal of Cancer
96. A comprehensive transcriptomic landscape of cholangiocarcinoma based on bioinformatics analysis from large cohort of patients
    Hongguang Li, Lingxin Qu, Haibin Zhang, Jun Liu, Xiaolu Zhang · 2021 · Scientific Reports
97. The Preventive Role of Hydrogen-Rich Water in Thioacetamide-Induced Cholangiofibrosis in Rat Assessed by Automated Histological Classification
    Chaofu Li, Xing Zhao, Xiaoqiang Gu, Ying Chen, Guanzhen Yu · 2021 · Frontiers in Pharmacology
98. Inositol 1,4,5-trisphosphate receptor type 3 (ITPR3) is overexpressed in cholangiocarcinoma and its expression correlates with S100 calcium-binding protein A4 (S100A4)
    Michele Ângela Rodrigues, Dawidson Assis Gomes, Ana Luiza Cosme, Marcelo Dias Sanches, Vívian Resende, Geovanni Dantas Cassali · 2021 · Biomedicine & Pharmacotherapy
99. Outcomes in patients receiving palliative chemotherapy for advanced biliary tract cancer
    Felix Thol, Simon Johannes Gairing, Carolin Czauderna, Thomas Thomaidis, Thomas Gamstätter, Yvonne Huber, Johanna� Vollmar, Johanna Lorenz, Maurice Stephan Michel, F. Bartsch et al. · 2021 · JHEP Reports
100. Development and external validation of a prediction model for overall survival after resection of distal cholangiocarcinoma
     Ali Belkouz, Stijn R. van Roessel, Marin Strijker, Jacob L. van Dam, Lois A. Daamen, Lydia G. van der Geest, Alberto Balduzzi, Andrea Benedetti Cacciaguerra, Susan van Dieren, Izaak Quintus Molenaar et al. · 2022 · British Journal of Cancer